EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial

Gal Tsaban iD, Genya Aharon-Hananel, Shiran Shalem, Hila Zelicha, Anat Yaskolka Meir, Dafna Pachter, Dana Tamar Goldberg, Omer Kamer, Liav Alufer, Meir J Stampfer, Dong D Wang, Lu Qi iD und 5 weitere

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15840 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Gal Tsaban und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Health and Nutrition Innovative International Research Centre, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cross-Over Studies, Postprandial Period, Blood Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Israel Ministry of Science and Technology, Israel Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To explore the effect of Mankai, a cultivated aquatic duckweed green plant, on postprandial glucose (PG) excursions in type 2 diabetes (T2D).

Methods

In a 4‐week, randomized crossover‐controlled trial, we enrolled 45 adults with T2D (HbA1c range: 6.5%‐8.5%) from two sites in Israel. Participants were randomized to drink Mankai (200 mL of raw‐fresh‐aquatic plant + 100 mL of water, 40 kcal, ~10 g of dry matter equivalent) or water (300 mL) following dinner, for 2 weeks each, with a 4‐day washout interval, without dietary, physical activity or pharmacotherapy alterations. We used continuous glucose monitoring (CGM) devices.

Results

Forty patients (adherence rate = 88.5%; 743 person‐intervention‐days, 68.9% men, age = 64 years, HbA1c = 6.8%) completed the study with a consistent diet and complete CGM reads. Only two‐thirds of the individuals responded beneficially to Mankai. Overall, Mankai significantly lowered the PG peak by 19.3% (∆peak = 24.3 ± 16.8 vs. 30.1 ± 18.5 mg/dL; P < .001) and delayed the time‐to‐peak by 20.0% (112.5 [interquartile range: 75‐135] vs. 90 [60‐105] min; P < .001) compared with water. The PG incline and decline slopes were shallower following postdinner Mankai (incline slope: 16.8 vs. water: 29.9 mg/[dL h]; P < .001; decline slope: −6.1 vs. water: −7.9 mg/[dL h]; P < .01). Mean postprandial net incremental area‐under‐the‐glucose‐curve was lowered by 20.1% with Mankai compared with water ( P = .03). Results were consistent across several sensitivity and subgroup analyses, including across antidiabetic pharmacotherapy treatment groups. Within 2 weeks, the triglycerides/high‐density lipoprotein cholesterol ratio in the Mankai group (−0.5 ± 1.3) decreased versus water (+0.3 ± 1.5, P = .05).

Conclusions

Mankai consumption may mitigate the PG response in people with T2D with an ~20% improvement in glycaemic values. These findings provide case‐study evidence for plant‐based treatments in T2D to complement a healthy lifestyle and pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cross-Over StudiesPostprandial PeriodBlood GlucoseHumansMaleMiddle AgedFemaleAgedGlycated HemoglobinAraceaeIsraelBlood Glucose Self-MonitoringGlycemic Control

Stichwörter der Autor:innen

Mankaicontinuous postprandial glucose monitoringglycaemic controlrandomized crossover trialtype 2 diabetes

Substanzen

Blood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • The Health and Nutrition Innovative International Research Centre, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheva, Israel.
  • Department of Cardiology, Soroka University Medical Centre, Beersheva, Israel.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Gal Tsaban, Lu Qi, Matthias Blüher

Förderung

  • Deutsche Forschungsgemeinschaft
  • Israel Ministry of Science and Technology
  • Israel Ministry of Health

Zitieren

APA

Tsaban, G., Aharon-Hananel, G., Shalem, S., Zelicha, H., Yaskolka Meir, A., Pachter, D., Goldberg, D. T., Kamer, O., Alufer, L., Stampfer, M. J., Wang, D. D., Qi, L., Blüher, M., Stumvoll, M., Hu, F. B., Shai, I., & Tirosh, A. (2024). The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15840

Vancouver

Tsaban G, Aharon-Hananel G, Shalem S, Zelicha H, Yaskolka Meir A, Pachter D, et al. The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15840

BibTeX
@article{Tsaban2024,
  author = {Tsaban, Gal and Aharon-Hananel, Genya and Shalem, Shiran and Zelicha, Hila and Yaskolka Meir, Anat and Pachter, Dafna and Goldberg, Dana Tamar and Kamer, Omer and Alufer, Liav and Stampfer, Meir J and Wang, Dong D and Qi, Lu and Blüher, Matthias and Stumvoll, Michael and Hu, Frank B and Shai, Iris and Tirosh, Amir},
  title = {The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15840}
}
Kostenlos starten →